The UQCRQ (Ubiquinol-Cytochrome C Reductase Core Protein Q) gene encodes a core component of mitochondrial complex III (cytochrome bc1 complex), also known as ubiquinol-cytochrome c reductase. This protein is essential for the mitochondrial electron transport chain and ATP production. Complex III is crucial for cellular energy metabolism, and its dysfunction is implicated in various neurodegenerative diseases.
Gene and Protein Structure
UQCRQ encodes a small mitochondrial protein (approximately 174 amino acids) that is a core component of complex III:
The UQCRQ (Ubiquinol-Cytochrome C Reductase Core Protein Q) gene encodes a core component of mitochondrial complex III (cytochrome bc1 complex), also known as ubiquinol-cytochrome c reductase. This protein is essential for the mitochondrial electron transport chain and ATP production. Complex III is crucial for cellular energy metabolism, and its dysfunction is implicated in various neurodegenerative diseases.
Gene and Protein Structure
UQCRQ encodes a small mitochondrial protein (approximately 174 amino acids) that is a core component of complex III:
Function: Part of the cytochrome bc1 complex that catalyzes electron transfer from ubiquinol to cytochrome c[@iwata1998]
The complex III dimer consists of multiple subunits, with UQCRQ being one of the small core proteins that provide structural stability[@hunte2005].
Normal Physiological Functions
Mitochondrial Electron Transport
Complex III (ubiquinol-cytochrome c reductase) performs a critical step in the mitochondrial respiratory chain:
Electron transfer: Transfers electrons from ubiquinol (QH2) to cytochrome c[@iwata1998]
Proton pumping: Pumps protons from the mitochondrial matrix to the intermembrane space
ATP synthesis: Creates the proton gradient used by complex V (ATP synthase) to produce ATP[@hunte2005]
Cellular Energy Metabolism
Mitochondria generate the majority of cellular ATP through oxidative phosphorylation. Complex III is essential for:
Maintaining cellular energy homeostasis
Supporting high-energy-demand processes in [neurons](/entities/neurons)
Regulating metabolic flux through the respiratory chain[@hunte2005]
Reactive Oxygen Species (ROS) Regulation
Complex III is a significant source of mitochondrial [ROS](/entities/reactive-oxygen-species). Under normal conditions, controlled ROS production serves as signaling molecules. The Q cycle in complex III is the primary site of superoxide production[@murphy2009].
Role in Neurodegeneration
Parkinson's Disease
Mitochondrial dysfunction is a central feature of Parkinson's disease (PD). Complex III impairment in dopaminergic neurons leads to:
Reduced ATP production in energy-demanding dopaminergic neurons
Increased ROS production leading to oxidative stress
Impaired calcium handling
Activation of apoptotic pathways
Genetic variants in mitochondrial complex III genes, including UQCRQ, have been associated with PD risk[@schapira2007][@pyle2015].
Alzheimer's Disease
In Alzheimer's disease (AD), mitochondrial dysfunction precedes classic pathological changes:
Complex III activity is reduced in AD brain tissue
Impaired electron transport leads to increased ROS and [amyloid-beta](/proteins/amyloid-beta) toxicity
Mitochondrial deficits contribute to synaptic failure and neuronal death[@manczak2006]
UQCRQ expression is altered in AD patient brains[@manczak2006]
Amyotrophic Lateral Sclerosis (ALS)
Mitochondrial dysfunction is a hallmark of ALS:
Complex III activity is decreased in ALS motor neurons
Energy deficits contribute to motor neuron degeneration
Altered mitochondrial function affects calcium homeostasis[@cozzolino2014]
Huntington's Disease
Mitochondrial complex III defects have been reported in Huntington's disease (HD):
Reduced complex III activity in HD brain and models
Energy deficits contribute to striatal neuron vulnerability[@tunez2013]
Expression Patterns
UQCRQ is ubiquitously expressed, with highest levels in:
[Iwata S, et al, Structure of cytochrome bc1 complex: protonmotive pathway and binding sites (1998)](https://pubmed.ncbi.nlm.nih.gov/9647906/)
[Hunte C, et al, Protonmotive pathway and mechanism in cytochrome bc1 complexes (2005)](https://pubmed.ncbi.nlm.nih.gov/15709855/)
[Murphy MP, How mitochondria produce reactive oxygen species (2009)](https://pubmed.ncbi.nlm.nih.gov/19154418/)
[Schapira AH, Mitochondrial dysfunction in Parkinson's disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17392362/)
[Pyle A, et al, Mitochondrial complex I activity in Parkinson's disease: a case-control study (2015)](https://pubmed.ncbi.nlm.nih.gov/25605958/)
[Manczak M, et al, Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression (2006)](https://pubmed.ncbi.nlm.nih.gov/16551656/)
[Cozzolino M, et al, Mitochondria: new frontiers in ALS pathogenesis and therapeutic targets (2014)](https://pubmed.ncbi.nlm.nih.gov/24270834/)
[Tunez I, et al, Mitochondrial dysfunction in Huntington's disease: pathogenesis and therapeutic opportunities (2013)](https://pubmed.ncbi.nlm.nih.gov/23643845/)
[Ko HS, et al, Gene therapy for mitochondrial disorders: recent advances (2015)](https://pubmed.ncbi.nlm.nih.gov/25881011/)